RECENT SCIENTIFIC PUBLICATIONS
Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection. Sullivan et al. (2022) Read here
Increasing uptake to a lung cancer screening programme: building with communities through co-design. Brown et al. BMC Public Health (2022) Read here
Psychological impact of lung cancer screening using a novel antibody blood test followed by imaging: the ECLS randomized controlled trial. J Hancox, K Ayling, L Bedford, S Schembri, F S Mair, R Littleford, D Kendrick. (2022) Read here
Using electronic medical records to identify potentially eligible study subjects for lung cancer screening with biomarkers. Brown et al. (2021) Read here
Can we achieve better recruitment by providing better information? Meta-analysis of ‘studies within a trial’ (SWATs) of optimised participant information sheets. Madurasinghe et al. (2021) Read here
Does recruitment via GP letter or community advertisement to cancer screening influence uptake across socioeconomic groups? Exploring recruitment methods in the Early detection of Cancer of the Lung Scotland (ECLS) trial. Scobie et al. International Journal of Behavioral Medicine. (2021) Read here
Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. Sullivan et al. Eur Respir J (2021) Read here
Early Diagnosis of Lung Cancer in people most at risk. Br J Gen Pract. Sullivan & Beusekom. (2020) Read here
Unconditional and conditional monetary incentives to increase response to mailed questionnaires: A randomized controlled study within a trial (SWAT). Young et al. J Eval Clin Pract (2020) Read here
Determinants of motivation to quit in smokers screened for the early detection of lung cancer: A qualitative study Young et al. BMC Public Health (2018) Read here
Primary care providers’ views on a future lung cancer screening program. O’Brien et al. Family Practice (2018) Read here
The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial Parker et al. Trials (2018) Read here
Lung cancer screening: Does pulmonary nodule detection affect a range of smoking behaviours? Clark et al. Journal of Public Health (2018) Read here
Lung cancer CT screening: psychological responses in the presence and absence of pulmonary nodules. Clark et al. Lung Cancer (2018) Read here
Serum and blood based biomarkers for lung cancer screening: a systematic review Chu et al. (2018) Read here
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial Sullivan et al. BMC Cancer. (2017) Read here
Piloting electronic screening forms in primary care: findings from a mixed methods study to identify patients eligible for low dose CT lung cancer screening O’Brien et al. BMC Family Practice. (2017) Read here
Factors influencing the decision to attend screening for cancer in the UK: a meta-ethnography of qualitative research Young et al. Journal of Public Health (2017) Read here
Exploring recruitment barriers and facilitators in early cancer detection trials: the use of pre-trial focus groups das Nair et al. Trials (2014) Read here (2014)
RECENT SCIENTIFIC PRESENTATIONS AND ABSTRACTS
FRIDAY, 25th JAN 2019 Tayside Cancer Research Symposium The second Tayside Cancer Research Symposium will be happening on Friday 25th January 2019 from 12.30 – 16.30 in the Wolfson Lecture Theatre at Ninewells Hospital.
An RCT of the Detection of Autoantibodies to Tumor Antigens in Lung Cancer Using the EarlyCDT-Lung Test in Scotland (ECLS) in 12208 Study Subjects Sullivan et al. (2017) Read here
A Randomised Controlled Study of Lung Cancer Screening in Scotland Using the Detection of Autoantibodies to Tumour Antigens (EarlyCDT-Lung Test) Dorward et al. (2016) Read here
Testing the effectiveness of user-tested patient information on recruitment rates across multiple trials: meta-analysis of data from the Start programme Bower et al. Trials (2015) Read here
A new partnership with biomarker research: a randomised controlled trial of the detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT-Lung test in Scotland (ECLS) Sullivan et al. European Journal of Cancer Care (2014)
Psychological impact of lung cancer screening using a novel antibody blood test followed by imaging: the ECLS randomized controlled trial. J Hancox, K Ayling, L Bedford, S Schembri, F S Mair, R Littleford, D Kendrick. Read here
Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. Sullivan et al. Eur Respir J (2021) Read here
Unconditional and conditional monetary incentives to increase response to mailed questionnaires: A randomized controlled study within a trial (SWAT). Young et al. J Eval Clin Pract (2020) Read here
Determinants of motivation to quit in smokers screened for the early detection of lung cancer: A qualitative study Young et al. BMC Public Health (2018) Read here
Primary care providers’ views on a future lung cancer screening program. O’Brien et al. Family Practice (2018) Read here
The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial Parker et al. Trials (2018) Read here
Lung cancer screening: Does pulmonary nodule detection affect a range of smoking behaviours? Clark et al. Journal of Public Health (2018) Read here
Lung cancer CT screening: psychological responses in the presence and absence of pulmonary nodules. Clark et al. Lung Cancer (2018) Read here
Serum and blood based biomarkers for lung cancer screening: a systematic review Chu et al. (2018) Read here
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial Sullivan et al. BMC Cancer (2017) Read here
Piloting electronic screening forms in primary care: findings from a mixed methods study to identify patients eligible for low dose CT lung cancer screening O’Brien et al. BMC Family Practice (2017) Read here
Factors influencing the decision to attend screening for cancer in the UK: a meta-ethnography of qualiative research Young et al. Journal of Public Health (2017) Read here
Exploring recruitment barriers and facilitators in early cancer detection trials: the use of pre-trial focus groups das Nair et al. Trials (2014) Read here (2014)
RECENT SCIENTIFIC PRESENTATIONS AND ABSTRACTS
FRIDAY, 25th JAN 2019 Tayside Cancer Research Symposium The second Tayside Cancer Research Symposium will be happening on Friday 25th January 2019 from 12.30 – 16.30 in the Wolfson Lecture Theatre at Ninewells Hospital.
An RCT of the Detection of Autoantibodies to Tumor Antigens in Lung Cancer Using the EarlyCDT-Lung Test in Scotland (ECLS) in 12208 Study Subjects Sullivan et al. (2017) Read here
A Randomised Controlled Study of Lung Cancer Screening in Scotland Using the Detection of Autoantibodies to Tumour Antigens (EarlyCDT-Lung Test) Dorward et al. (2016) Read here
Testing the effectiveness of user-tested patient information on recruitment rates across multiple trials: meta-analysis of data from the Start programme Bower et al. Trials (2015) Read here
A new partnership with biomarker research: a randomised controlled trial of the detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT-Lung test in Scotland (ECLS) Sullivan et al. European Journal of Cancer Care (2014)